BIOS 11. Leadership Lessons Pt. 2: Mark Pulido - Former CEO @ McKesson / Novartis
Mark Pulido is a 5 time CEO & industry veteran with 4+ decades of leadership experience spanning Health IT, Health Services, Big Pharma, Diagnostics, Private Equity, & Venture Back Startups.
He is the former President & CEO @ ABILITY, a national leader in cloud-based solutions for the healthcare provider marketplace acquired for $1.2B by Inovalon in 2018 - where he currently serves on The Board of Directors. Prior to his role at ABILITY, Mark focused on private equity and investing initiatives as an industry executive at Freeman Spogli. Previously he served as President & Chief Executive Officer @ BenefitPoint, an early stage Sequoia capital-backed employee benefits technology company.
Prior to that, he led several of the most prominent healthcare and information technology companies in the world. Mark served as President & CEO @ McKesson Corporation, a Fortune 10 healthcare services and information technology company; President & Chief Executive Officer @ Novartis Pharmaceuticals Corporation, USA (formerly Sandoz), a research-based pharmaceutical manufacturer; and Chairman, President & CEO @ Red Line Healthcare Corporation, a specialty long-term care distribution and medical billing company. He also served as Chairman of the Board of Directors @ Quidel, a manufacturer of diagnostic testing solutions and as a Board Member of several healthcare and technology companies, including Sunrise Medical, a medical equipment manufacturer; Smile Brands Group, a dental practice management company; Charles Schwab, a financial services company; and Imation, a technology company.
Outside of work, you can find Mark pursuing his passion for wine making at Pulido~Walker Cellars and supporting the community through Pulido~Walker Foundation focusing on education for youth at risk.
Thank you for listening!
BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.